Editorial: Molecular drivers of immunothrombosis

Alice Assinger; Madhumita Chatterjee; James D McFadyen

doi:10.3389/fimmu.2024.1385966

Editorial: Molecular drivers of immunothrombosis

Front Immunol. 2024 Feb 27:15:1385966. doi: 10.3389/fimmu.2024.1385966. eCollection 2024.

Authors

Alice Assinger¹, Madhumita Chatterjee², James D McFadyen³

Affiliations

¹ Institute of Vascular Biology and Thrombosis Research, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
² Department of Pharmacology, Experimental Therapy and Toxicology, University Hospital Tübingen, Tübingen, Germany.
³ Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.

No abstract available

Keywords: immune response; immunothrombosis; infection; inflammation; platelets.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Blood Coagulation*
Hemostasis
Humans
Thromboinflammation*

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work is financially supported by the Austrian Federal Ministry of Education, Science and Research, the Medical-Scientific Fund of the Mayor of Vienna (COVID024) and the Austrian Science Fund (P32064 and P34783) to AA and by German Research Foundation DFG-Project number DFG-464254052 (RTG2816) to MC. JM is supported by a Heart Foundation Future Leader Fellowship.